CLASS II Drug recall · Reported 15 May 2024 · FDA Enforcement Report

Timolol Maleate Ophthalmic Solution recalled by FDC

FDC is recalling Timolol Maleate Ophthalmic Solution, USP, 5%, distributed in New Jersey. The recall was initiated on 25 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.
NDC64980-513, 64980-514
UPC0364980513050
Quantity recalled382,104 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0488-2024
FDA event ID
94466
Recalling firm
FDC, Aurangabad, Maharashtra State, N/A
Manufacturer
Rising Pharma Holdings, Inc.
Classification
Class II
Status
Terminated
Recall initiated
25 Apr 2024
FDA classified
7 May 2024
Reported
15 May 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects
Drug class
Eye Drops

Timeline

25 Apr 2024Recall initiated by company
7 May 2024Classified by FDA+12 days
15 May 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx only, Manufactured by: FDC Limited, Maharashtra, India, Distributed by: Rising Pharmaceuticals, Inc, NJ

Where it was distributed

New Jersey Only

New Jersey

Questions about this recall

Is Timolol Maleate Ophthalmic Solution, USP, 5% recalled?

Yes. FDC recalled Timolol Maleate Ophthalmic Solution, USP, 5% on 25 Apr 2024. The recall is Class II and its status is Terminated. Recall number D-0488-2024.

Why was it recalled?

Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.

Which lots are affected?

Lot #: a) 083H008, Exp. Date 07/2025; 083G003, Exp. Date 06/2025; 083J017, Exp. Date 09/2025; b) 083I013, Exp. Date 08/2025.

Where was it sold?

New Jersey Only

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from FDC

All 11

Other Timolol recalls

All 11